| Financial Year |
March 31 2023 |
| Monetary Funds |
859,506,015.54 |
| Held-for-trading Financial Assets |
55,034,104.46 |
| Notes Receivable |
38,443,943.68 |
| Accounts Receivable |
586,260,677.26 |
| Advances to Suppliers |
29,481,725.39 |
| Other Receivables |
59,462,216.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
835,605,968.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
91,931,624.58 |
| Total Current Assets |
2,608,811,734.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
904,493,800.83 |
| Investment Properties |
32,632,590.61 |
| Fixed Assetes |
1,432,835,979.65 |
| Under-construction Projects |
40,131,154.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,697,586.39 |
| R&D expenses |
21,802,804.81 |
| Goodwill |
319,829,693.57 |
| Long-Term Deferred and Prepaid Expenses |
40,005,969.15 |
| Deferred Income Tax Assets |
36,050,936.51 |
| Other Non-Current Assets |
64,526,700.61 |
| Sub-Total of Non-Current Assets |
3,069,775,833.66 |
| Total Assets |
5,678,587,568.53 |
| Short-Term Loans |
756,113,491.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
86,912,694.14 |
| Accounts Payable |
234,149,445.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,230,942.70 |
| Taxes Payable |
13,235,206.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,336,735.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,894,214.64 |
| Other Current Liabilities |
3,573,170.60 |
| Sub-Total of Current Liabilities |
1,281,019,806.45 |
| Long-term Loans |
-- |
| Bonds Payable |
794,871,669.93 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,298,351.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
873,245,959.94 |
| Total Liabilities |
2,154,265,766.39 |
| Paid-In Capital(Or Share Stock) |
655,203,955.00 |
| Capital Surplus |
871,127,507.86 |
| Surplus Reserve |
370,552,442.95 |
| LESS:Treasury Stock |
16,698,900.78 |
| Undistributed Profits |
1,196,341,520.91 |
| Minority Stockholder's Interest |
269,503,160.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,254,818,641.22 |
| Owner's Equity（Stockholder's Equity） |
3,524,321,802.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,678,587,568.53 |
